7TM Pharma Has Initiated Phase I/IIa Clinical Trial with TM30339  
9/2/2008 11:45:41 AM

7TM Pharma today announced that it has initiated a Phase I/IIa clinical trial with the drug candidate TM30339, which was discovered internally at 7TM Pharma and is being developed for treatment of obesity and related metabolic disorders.